hERG potassium channel inhibition by ivabradine may contribute to QT prolongation and risk of torsades de pointes.
about
hERG potassium channel inhibition by ivabradine may contribute to QT prolongation and risk of torsades de pointes.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
hERG potassium channel inhibit ...... d risk of torsades de pointes.
@ast
hERG potassium channel inhibit ...... d risk of torsades de pointes.
@en
type
label
hERG potassium channel inhibit ...... d risk of torsades de pointes.
@ast
hERG potassium channel inhibit ...... d risk of torsades de pointes.
@en
prefLabel
hERG potassium channel inhibit ...... d risk of torsades de pointes.
@ast
hERG potassium channel inhibit ...... d risk of torsades de pointes.
@en
P2093
P2860
P50
P356
P1476
hERG potassium channel inhibit ...... nd risk of torsades de pointes
@en
P2093
Christopher E Dempsey
Dario Melgari
Jules C Hancox
P2860
P304
P356
10.1177/2042098615595546
P577
2015-08-01T00:00:00Z